The coming IPO parade

Jul 19, 2013

Dan Primack was a senior editor at Fortune from 2010 to 2016. He was also the author of Term Sheet, Fortune's daily newsletter about deals and dealmakers.

FORTUNE -- It's been a busy few days for IPOs, and things only are expected to heat up next week.

Seven companies have priced on U.S. exchanges since Tuesday, including last night's $191 million raise for digital coupon marketplace RetailMeNot (sale). It hopes to mimic the 60% aftermarket bump achieved yesterday by cancer "stem cell" company OncoMed Pharmaceuticals (omed).

On tap next week are a whopping eleven offerings:

Next week's calender doesn't include anything huge, but it could be interesting to see if OncoMed provides any halo effect to any of the five VC-backed biotechs. I'd expect us to see some larger offerings come fall, which is when IPO volume traditionally increases.

Some additional IPO thoughts from an interview I did this morning on CNBC:

[cnnmoney-cnbc vid=http://video.cnbc.com/gallery/?video=3000184241]

All products and services featured are based solely on editorial selection. FORTUNE may receive compensation for some links to products and services on this website.

Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions